Targeting Bcl-2 in CLL
Keywords: ABT-263; ABT-737; Antileukemic therapy; BH3 domain mimetics; CLL; antisense oligonucleotides; gossypol derivatives; microRNA-15a/16-1; obatoclax; oblimersen; small molecular Bcl-2 inhibitors
Document Type: Research Article
Publication date: 2012-10-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.